Montelukast Sodium

CAS 151767-02-1 21 current records 5 historicalSmall Molecule

Who holds supplier records for Montelukast Sodium? 21 organisations hold a current record for Montelukast Sodium: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (15), China (2), Netherlands (1), Taiwan (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Montelukast Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/montelukast-sodium

Reading the evidence

  • 21 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    15 of the 20 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (21)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Montelukast Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

India15China2Netherlands1Taiwan1Canada1Country not recorded for 1
Need Montelukast Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (14)

Certificates of Suitability on the EDQM register for Montelukast Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 24 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2026-108 - Rev 00
Montelukast sodium, Process-II, LT code
Nov 2026—
MSN PHARMACHEM PRIVATE LIMITED SangareddyIN
CEP 2012-091 - Rev 02
Montelukast sodium, Amorphous, Micronised, Non-micronised and Sifted
Jun 2026—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2024-125 - Rev 00
Montelukast sodium
Dec 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2011-245 - Rev 04
Montelukast sodium
Oct 2025—
TAPI NL B.V. AmsterdamNL
CEP 2011-131 - Rev 03
Montelukast sodium
Mar 2025—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2024-390 - Rev 00
Montelukast sodium, 1556
Feb 2025—
HETERO DRUGS LIMITED HyderabadIN
CEP 2012-318 - Rev 02
Montelukast sodium
Dec 2024—
MOREPEN LABORATORIES LIMITED BaddiIN
CEP 2012-003 - Rev 02
Montelukast sodium, Milled and micronised
Dec 2024Inspected Mar 2026
Spain
LAURUS LABS LIMITED HyderabadIN
CEP 2013-311 - Rev 02
Montelukast sodium, Alternate process
Nov 2024—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2012-115 - Rev 03
Montelukast sodium
Jul 2023—
MELODY HEALTHCARE PVT. LTD. BoisarIN
R1-CEP 2011-319 - Rev 02
Montelukast sodium
Feb 2023—
SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. LinyiCN
R0-CEP 2019-211 - Rev 00
Montelukast sodium
Jun 2022—
FORMOSA LABORATORIES, INC. TaoyuanTW
R1-CEP 2013-278 - Rev 00
Montelukast sodium
Jul 2021—
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou CityCN
R1-CEP 2014-115 - Rev 01
Montelukast sodium
Jul 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Montelukast Sodium are no longer active. These show a past filing, not current supply.

Show all 5 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Montelukast Sodium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200681).

Chemical identity

IUPAC name
sodium 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate
Canonical SMILES
CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+]
InChIKey
LBFBRXGCXUHRJY-HKHDRNBDSA-M
Synonyms
MK-476, Montelukast (as sodium), Montelukast monosodium salt, Montelukast sodium, NSC-759107, Singulair

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Leukotriene Receptor Antagonist
Mechanism of action
Leukotriene Receptor Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Montelukast Sodium?

21 organisations hold an active US FDA Type II Drug Master File or a CEP for Montelukast Sodium: APITORIA PHARMA PRIVATE LTD (India), MSN PHARMACHEM PRIVATE LTD (India), TAPI NL BV (Netherlands), Dr. Reddy's Laboratories Ltd. (India), Formosa Laboratories, Inc. (Taiwan), Hetero Drugs Limited (India), Laurus Labs Limited (India) and Macleods Pharmaceuticals Ltd. (India), and 13 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Montelukast Sodium Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 43282, 27234), MSN PHARMACHEM PRIVATE LTD (DMF 22484, 20580), TAPI NL BV (DMF 31413, 19829), Dr. Reddy's Laboratories Ltd. (DMF 20035, 24516), Formosa Laboratories, Inc. (DMF 21702), Hetero Drugs Limited (DMF 24667), Laurus Labs Limited (DMF 23736) and Macleods Pharmaceuticals Ltd. (DMF 25104) and 12 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Montelukast Sodium records mean?

5 organisations have only inactive Type II DMFs for Montelukast Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Montelukast Sodium have a European Certificate of Suitability?

Yes. 14 organisations hold a valid CEP for Montelukast Sodium on the EDQM register, including APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), TAPI NL B.V. Amsterdam (NL) and MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Montelukast Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Montelukast Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.